60 Degrees Pharmaceuticals Inc. Common Stock (SXTP)

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

60 Degrees Pharmaceuticals Inc. Common Stock (SXTP) is down 27.7% since the beginning of the year. At $1 per share, SXTP is trading 88.7% below its 52-week high of $13.

60 Degrees Pharmaceuticals Inc. Common Stock (SXTP) has returned -27.70% so far this year and -87.37% over the past 12 months.

Based on dividend-adjusted daily data since Jul 12, 2023, SXTP's average daily return is -0.46%, while the average monthly return is -10.32%.

Historically, 28% of months were positive and 72% were negative. The best month was Jan 2026 with a return of +104.1%, while the worst month was Jan 2024 at -72.5%. The longest winning streak lasted 2 consecutive months, and the longest losing streak was 5 months.

On a daily basis, SXTP closed higher 40% of trading days. The best single day was Jan 22, 2026 with a return of +152.0%, while the worst single day was Jan 30, 2024 at -40.6%.

60 Degrees Pharmaceuticals Inc. Common Stock has an annualized alpha of -69.89%, beta of 0.16, and R2 of 0.00 versus S&P 500 Index. Calculated based on daily prices since July 13, 2023.

• This stock participated in 365.12% of S&P 500 Index downside but only -147.48% of its upside - more exposed to losses than it benefited from rallies.
• Beta of 0.16 may look defensive, but with R2 of 0.00 this stock is largely uncorrelated with S&P 500 Index - low beta reflects independence, not downside protection. See the Volatility section for a true picture of this stock's risk.
• R2 of 0.00 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

SXTP ranks 12 for risk / return — in the bottom 12% of stocks on our site. This means you're taking on significantly more risk than the returns justify. Consider whether the potential upside is worth the volatility, or explore alternatives with better risk / return profiles.

The table below present risk-adjusted performance metrics for 60 Degrees Pharmaceuticals Inc. Common Stock (SXTP) and compare them to S&P 500 Index.

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the 60 Degrees Pharmaceuticals Inc. Common Stock. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the 60 Degrees Pharmaceuticals Inc. Common Stock was 99.88%, occurring on May 15, 2026. The portfolio has not yet recovered.

The current 60 Degrees Pharmaceuticals Inc. Common Stock drawdown is 99.87%.

The chart below shows the rolling one-month volatility.

The chart below illustrates the trends in the financial health of 60 Degrees Pharmaceuticals Inc. Common Stock over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

The Valuation section provides an overview of how 60 Degrees Pharmaceuticals Inc. Common Stock is priced in the market compared to other companies in the Biotechnology industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.